|  Help  |  About  |  Contact Us

Publication : BMAL1 loss in oligodendroglia contributes to abnormal myelination and sleep.

First Author  Rojo D Year  2023
Journal  Neuron Volume  111
Issue  22 Pages  3604-3618.e11
PubMed ID  37657440 Mgi Jnum  J:342974
Mgi Id  MGI:7561447 Doi  10.1016/j.neuron.2023.08.002
Citation  Rojo D, et al. (2023) BMAL1 loss in oligodendroglia contributes to abnormal myelination and sleep. Neuron 111(22):3604-3618.e11
abstractText  Myelination depends on the maintenance of oligodendrocytes that arise from oligodendrocyte precursor cells (OPCs). We show that OPC-specific proliferation, morphology, and BMAL1 are time-of-day dependent. Knockout of Bmal1 in mouse OPCs during development disrupts the expression of genes associated with circadian rhythms, proliferation, density, morphology, and migration, leading to changes in OPC dynamics in a spatiotemporal manner. Furthermore, these deficits translate into thinner myelin, dysregulated cognitive and motor functions, and sleep fragmentation. OPC-specific Bmal1 loss in adulthood does not alter OPC density at baseline but impairs the remyelination of a demyelinated lesion driven by changes in OPC morphology and migration. Lastly, we show that sleep fragmentation is associated with increased prevalence of the demyelinating disorder multiple sclerosis (MS), suggesting a link between MS and sleep that requires further investigation. These findings have broad mechanistic and therapeutic implications for brain disorders that include both myelin and sleep phenotypes.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

16 Bio Entities

Trail: Publication

0 Expression